Satellos Bioscience Inc (MSCL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1 | 11 | 80 | 84 | 86 |
| Accounts receivable | 145 | -35 | 0 | 269 | -24 |
| Other Working Capital | 201 | 573 | -73 | 668 | -437 |
| Other Operating Activity | -1,221 | -1,454 | -1,162 | -1,679 | -1,301 |
| Operating Cash Flow | $-874 | $-904 | $-1,155 | $-658 | $-1,676 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -2 | 0 | -1 |
| Investing Cash Flow | $0 | $0 | $-2 | $0 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,659 | 0 | 0 | N/A | N/A |
| Common Stock Issued | N/A | -564 | 2,034 | 0 | 0 |
| Other Financing Activity | 0 | 574 | 0 | 0 | 0 |
| Financing Cash Flow | $1,659 | $10 | $2,034 | $0 | $0 |
| Exchange Rate Effect | -1 | -5 | -1 | 2 | -1 |
| Beginning Cash Position | 1,422 | 2,289 | 1,412 | 2,154 | 3,902 |
| End Cash Position | 2,206 | 1,417 | 2,289 | 1,498 | 2,223 |
| Net Cash Flow | $785 | $-894 | $878 | $-658 | $-1,677 |
| Free Cash Flow | |||||
| Operating Cash Flow | -874 | -904 | -1,155 | -658 | -1,676 |
| Capital Expenditure | N/A | 0 | -2 | N/A | -1 |
| Free Cash Flow | -874 | -905 | -1,156 | -658 | -1,677 |